A Novel Variant in the <i>TAMM41</i> ‐Associated Mitochondrial Myopathy

Pathogenic variants in TAMM41 were recently linked to mitochondrial myopathy, presenting with neonatal hypotonia, generalized weakness, developmental delay, ptosis, and ophthalmoparesis. Here, we present a long-term follow-up of an additional case, a Brazilian patient harboring a novel TAMM41 variant in compound heterozygosity with a previously described pathogenic variant. Patient exhibited mild developmental delay, acquired independent gait, but subsequently developed motor regression and weakness associated with recurrent infections, severe axial involvement, and marked restrictive pulmonary dysfunction. Muscle biopsy revealed decreased COX and SDH staining, which may serve as an important diagnostic clue for this condition. This case expanded the genetic spectrum of TAMM41-related mitochondrial myopathy and provided a brief review of disorders associated with reduced SDH staining.

Authors

Institutions

Publication Details

Journal
American Journal of Medical Genetics Part A
Published
2025-12-23
DOI
https://doi.org/10.1002/ajmga.70034
Primary Topic
Mitochondrial Function and Pathology
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

A Novel Variant in the TAMM41 ‐Associated Mitochondrial Myopathy

Alulin Tácio Quadros Santos Monteiro Fonseca, David Schlesinger, Clara Camelo Gontijo, Edmar Zanoteli et al.
American Journal of Medical Genetics Part A
Mitochondrial Function and Pathology
article

A Novel Variant in the TAMM41 ‐Associated Mitochondrial Myopathy

Alulin Tácio Quadros Santos Monteiro Fonseca, David Schlesinger, Clara Camelo Gontijo, Edmar Zanoteli, Rita Horvath, Cristiane Araujo Martins Moreno
article en

Abstract

Pathogenic variants in TAMM41 were recently linked to mitochondrial myopathy, presenting with neonatal hypotonia, generalized weakness, developmental delay, ptosis, and ophthalmoparesis. Here, we present a long-term follow-up of an additional case, a Brazilian patient harboring a novel TAMM41 variant in compound heterozygosity with a previously described pathogenic variant. Patient exhibited mild developmental delay, acquired independent gait, but subsequently developed motor regression and weakness associated with recurrent infections, severe axial involvement, and marked restrictive pulmonary dysfunction. Muscle biopsy revealed decreased COX and SDH staining, which may serve as an important diagnostic clue for this condition. This case expanded the genetic spectrum of TAMM41-related mitochondrial myopathy and provided a brief review of disorders associated with reduced SDH staining.

American Journal of Medical Genetics Part A
University of Cambridge (GB), Mendelics (BR), Hospital das Clínicas da Faculdade de Medicina da Universidade de São Paulo (BR)
Openalex Percentile: Top 36%
Mitochondrial Function and Pathology
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

A Novel Variant in the <i>TAMM41</i> ‐Associated Mitochondrial Myopathy — Alulin Tácio Quadros Santos Monteiro Fonseca, David Schlesinger, et al. · American Journal of Medical Genetics Part A (2025) | TGRS Research Map | TGRS